Tower Research Capital (TRC)’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,624
| Closed | -$17.5K | – | 6275 |
|
|
2023
Q3 | $17.5K | Sell |
2,624
-4,319
| -62% | -$28.8K | ﹤0.01% | 3499 |
|
|
2023
Q2 | $62.9K | Buy |
6,943
+3,862
| +125% | +$35K | ﹤0.01% | 2374 |
|
|
2023
Q1 | $22K | Buy |
3,081
+1,340
| +77% | +$9.57K | ﹤0.01% | 3362 |
|
|
2022
Q4 | $13K | Sell |
1,741
-9,142
| -84% | -$68.3K | ﹤0.01% | 3657 |
|
|
2022
Q3 | $84K | Sell |
10,883
-660
| -6% | -$5.09K | ﹤0.01% | 2717 |
|
|
2022
Q2 | $79K | Buy |
+11,543
| New | +$79K | ﹤0.01% | 2479 |
|
|
2022
Q1 | – | Sell |
-8,164
| Closed | -$46K | – | 6779 |
|
|
2021
Q4 | $46K | Buy |
8,164
+4,303
| +111% | +$24.2K | ﹤0.01% | 2829 |
|
|
2021
Q3 | $30K | Buy |
+3,861
| New | +$30K | ﹤0.01% | 3383 |
|
|
2021
Q2 | – | Sell |
-220
| Closed | -$2K | – | 5985 |
|
|
2021
Q1 | $2K | Buy |
+220
| New | +$2K | ﹤0.01% | 5073 |
|